Literature DB >> 26534901

Pancreatic Cancer Metabolism: Breaking It Down to Build It Back Up.

Rushika M Perera1, Nabeel Bardeesy1.   

Abstract

UNLABELLED: How do cancer cells escape tightly controlled regulatory circuits that link their proliferation to extracellular nutrient cues? An emerging theme in cancer biology is the hijacking of normal stress response mechanisms to enable growth even when nutrients are limiting. Pancreatic ductal adenocarcinoma (PDA) is the quintessential aggressive malignancy that thrives in nutrient-poor, hypoxic environments. PDAs overcome these limitations through appropriation of unorthodox strategies for fuel source acquisition and utilization. In addition, the interplay between evolving PDA and whole-body metabolism contributes to disease pathogenesis. Deciphering how these pathways function and integrate with one another can reveal novel angles of therapeutic attack. SIGNIFICANCE: Alterations in tumor cell and systemic metabolism are central to the biology of pancreatic cancer. Further investigation of these processes will provide important insights into how these tumors develop and grow, and suggest new approaches for its detection, prevention, and treatment. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26534901      PMCID: PMC4687899          DOI: 10.1158/2159-8290.CD-15-0671

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  140 in total

1.  Plasma 25-hydroxyvitamin D and risk of pancreatic cancer.

Authors:  Brian M Wolpin; Kimmie Ng; Ying Bao; Peter Kraft; Meir J Stampfer; Dominique S Michaud; Jing Ma; Julie E Buring; Howard D Sesso; I-Min Lee; Nader Rifai; Barbara B Cochrane; Jean Wactawski-Wende; Rowan T Chlebowski; Walter C Willett; JoAnn E Manson; Edward L Giovannucci; Charles S Fuchs
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-11-15       Impact factor: 4.254

2.  RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma.

Authors:  Martin C Whittle; Kamel Izeradjene; P Geetha Rani; Libing Feng; Markus A Carlson; Kathleen E DelGiorno; Laura D Wood; Michael Goggins; Ralph H Hruban; Amy E Chang; Philamer Calses; Shelley M Thorsen; Sunil R Hingorani
Journal:  Cell       Date:  2015-05-21       Impact factor: 41.582

3.  A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy.

Authors:  Baptiste Ronan; Odile Flamand; Lionel Vescovi; Christine Dureuil; Laurence Durand; Florence Fassy; Marie-France Bachelot; Annabelle Lamberton; Magali Mathieu; Thomas Bertrand; Jean-Pierre Marquette; Youssef El-Ahmad; Bruno Filoche-Romme; Laurent Schio; Carlos Garcia-Echeverria; Hélène Goulaouic; Benoit Pasquier
Journal:  Nat Chem Biol       Date:  2014-10-19       Impact factor: 15.040

Review 4.  AMPK: positive and negative regulation, and its role in whole-body energy homeostasis.

Authors:  D Grahame Hardie
Journal:  Curr Opin Cell Biol       Date:  2014-09-26       Impact factor: 8.382

5.  Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivors.

Authors:  Shinichi Yachida; Catherine M White; Yoshiki Naito; Yi Zhong; Jacqueline A Brosnan; Anne M Macgregor-Das; Richard A Morgan; Tyler Saunders; Daniel A Laheru; Joseph M Herman; Ralph H Hruban; Alison P Klein; Siân Jones; Victor Velculescu; Christopher L Wolfgang; Christine A Iacobuzio-Donahue
Journal:  Clin Cancer Res       Date:  2012-09-18       Impact factor: 12.531

6.  Atg7 Overcomes Senescence and Promotes Growth of BrafV600E-Driven Melanoma.

Authors:  Xiaoqi Xie; Ju Yong Koh; Sandy Price; Eileen White; Janice M Mehnert
Journal:  Cancer Discov       Date:  2015-02-11       Impact factor: 39.397

7.  Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.

Authors:  Andrew J Aguirre; Nabeel Bardeesy; Manisha Sinha; Lyle Lopez; David A Tuveson; James Horner; Mark S Redston; Ronald A DePinho
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

8.  Functional role of autophagy-mediated proteome remodeling in cell survival signaling and innate immunity.

Authors:  Robin Mathew; Sinan Khor; Sean R Hackett; Joshua D Rabinowitz; David H Perlman; Eileen White
Journal:  Mol Cell       Date:  2014-08-28       Impact factor: 17.970

9.  Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer.

Authors:  Suresh T Chari; Cynthia L Leibson; Kari G Rabe; Lawrence J Timmons; Jeanine Ransom; Mariza de Andrade; Gloria M Petersen
Journal:  Gastroenterology       Date:  2007-10-26       Impact factor: 22.682

Review 10.  Molecular Pathways: Is AMPK a Friend or a Foe in Cancer?

Authors:  D Grahame Hardie
Journal:  Clin Cancer Res       Date:  2015-07-07       Impact factor: 12.531

View more
  62 in total

1.  Treatment of Pancreatic Cancer Patient-Derived Xenograft Panel with Metabolic Inhibitors Reveals Efficacy of Phenformin.

Authors:  N V Rajeshkumar; Shinichi Yabuuchi; Shweta G Pai; Elizabeth De Oliveira; Jurre J Kamphorst; Joshua D Rabinowitz; Héctor Tejero; Fátima Al-Shahrour; Manuel Hidalgo; Anirban Maitra; Chi V Dang
Journal:  Clin Cancer Res       Date:  2017-06-13       Impact factor: 12.531

2.  Oral squamous cell carcinoma diagnosed from saliva metabolic profiling.

Authors:  Xiaowei Song; Xihu Yang; Rahul Narayanan; Vishnu Shankar; Sathiyaraj Ethiraj; Xiang Wang; Ning Duan; Yan-Hong Ni; Qingang Hu; Richard N Zare
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-29       Impact factor: 11.205

3.  A Serum-Induced Transcriptome and Serum Cytokine Signature Obtained at Diagnosis Correlates with the Development of Early Pancreatic Ductal Adenocarcinoma Metastasis.

Authors:  Susan Tsai; Laura McOlash; Shuang Jia; Jian Zhang; Pippa Simpson; Mary L Kaldunski; Mohammed Aldakkak; Jenny Grewal; Katie Palen; Michael B Dwinell; Bryon D Johnson; Alexander Mackinnon; Martin J Hessner; Jill A Gershan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-12-07       Impact factor: 4.254

Review 4.  The lysosome as a cellular centre for signalling, metabolism and quality control.

Authors:  Rosalie E Lawrence; Roberto Zoncu
Journal:  Nat Cell Biol       Date:  2019-01-02       Impact factor: 28.824

5.  Macrophage-Released Pyrimidines Inhibit Gemcitabine Therapy in Pancreatic Cancer.

Authors:  Christopher J Halbrook; Corbin Pontious; Ilya Kovalenko; Laura Lapienyte; Stephan Dreyer; Ho-Joon Lee; Galloway Thurston; Yaqing Zhang; Jenny Lazarus; Peter Sajjakulnukit; Hanna S Hong; Daniel M Kremer; Barbara S Nelson; Samantha Kemp; Li Zhang; David Chang; Andrew Biankin; Jiaqi Shi; Timothy L Frankel; Howard C Crawford; Jennifer P Morton; Marina Pasca di Magliano; Costas A Lyssiotis
Journal:  Cell Metab       Date:  2019-02-28       Impact factor: 27.287

6.  Associations between metabolites and pancreatic cancer risk in a large prospective epidemiological study.

Authors:  Rachael Stolzenberg-Solomon; Andriy Derkach; Steven Moore; Stephanie J Weinstein; Demetrius Albanes; Joshua Sampson
Journal:  Gut       Date:  2020-02-14       Impact factor: 23.059

Review 7.  Emerging role of tumor cell plasticity in modifying therapeutic response.

Authors:  Siyuan Qin; Jingwen Jiang; Yi Lu; Edouard C Nice; Canhua Huang; Jian Zhang; Weifeng He
Journal:  Signal Transduct Target Ther       Date:  2020-10-07

8.  Modulation of redox metabolism negates cancer-associated fibroblasts-induced treatment resistance in a heterotypic 3D culture platform of pancreatic cancer.

Authors:  Mans Broekgaarden; Sriram Anbil; Anne-Laure Bulin; Girgis Obaid; Zhiming Mai; Yan Baglo; Imran Rizvi; Tayyaba Hasan
Journal:  Biomaterials       Date:  2019-08-12       Impact factor: 12.479

Review 9.  Intracellular and extracellular TGF-β signaling in cancer: some recent topics.

Authors:  Kohei Miyazono; Yoko Katsuno; Daizo Koinuma; Shogo Ehata; Masato Morikawa
Journal:  Front Med       Date:  2018-07-24       Impact factor: 4.592

10.  Stromal epigenetic alterations drive metabolic and neuroendocrine prostate cancer reprogramming.

Authors:  Rajeev Mishra; Subhash Haldar; Veronica Placencio; Anisha Madhav; Krizia Rohena-Rivera; Priyanka Agarwal; Frank Duong; Bryan Angara; Manisha Tripathi; Zhenqiu Liu; Roberta A Gottlieb; Shawn Wagner; Edwin M Posadas; Neil A Bhowmick
Journal:  J Clin Invest       Date:  2018-07-26       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.